Altered immune responses in interleukin 10 transgenic mice

Journal of Experimental Medicine

Volumn 185, Issue 12, 1997, Pages 2101-2110

  Hagenbaugh, Amy ^a   Sharma, Sherven ^b,c   Dubinett, Steven M ^b,c   Wei, Sherry H Y ^f   Aranda, Richard ^a   Cheroutre, Hilde ^a   Fowell, Deborah J ^d   Binder, Scott ^e   Tsao, Betty ^a   Locksley, Richard M ^d   Moore, Kevin W ^f   Kronenberg, Mitchell ^a,g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Nephrology Section (1111)   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Midway Hospital Medical Center   (United States)

^f MERCK RESEARCH LABORATORIES   (United States)

^g LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; HELPER CELL; IMMUNE RESPONSE; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; THYMOCYTE; TRANSGENIC MOUSE;

ANIMALS; CELLS, CULTURED; COLITIS; FEMALE; IMMUNITY; INTERLEUKIN-10; LEISHMANIASIS, CUTANEOUS; LUNG NEOPLASMS; LYMPHOCYTES; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC;

EID: 0030942666     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.12.2101     Document Type: Article

References (43)

1. + T cells. Immunol. Rev. 123: 209-229.
2. Fiorentino, D.F., M.W. Bond, and T.R. Mosmann. 1989. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081-2095.
3. Ho, A.S., and K.W. Moore. 1994. Interleukin-10 and its receptor. Ther. Immunol. 1:173-185.
4. Hsieh, C.S., A.B. Heimberger, J.S. Gold, A. O'Garra, and K.M. Murphy. 1992. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an αβ T-cell-receptor transgenic system. Proc. Natl. Acad. Sci. USA. 89: 6065-6069.
5. Ding, L., and E.M. Shevach. 1992. IL-10 inhibits mitogeninduced T cell proliferation by selectively inhibiting macrophage costimulatory function. J. Immunol. 148:3133-3139.
6. Ding, L., P.S. Linsley, L.Y. Huang, R.N. Germain, and E.M. Shevach. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151:1224-1234.
7. Fiorentino, D.F., A. Zlotnik, T.R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815-3822.
8. Fiorentino, D.F., A. Zlotnik, P. Vieira, T.R. Mosmann, M. Howard, K.W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:3444-3451.
9. Moore, K.W., A. O'Garra, R. de Waal Malefyt, P. Vieira, and T.R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165-190.
10. Kim, J.M., C.I. Brannan, N.G. Copeland, N.A. Jenkins, T.A. Khan, and K.W. Moore. 1992. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J. Immunol. 148:3618-3623.
11. Tsao, B.P., K. Ohnishi, H. Cheroutre, B. Mitchell, M. Teitell, P. Mixter, M. Kronenberg, and B.H. Hahn. 1992. Failed self-tolerance and autoimmunity in IgG anti-DNA transgenic mice. J. Immunol. 149:350-358.
12. high T cells to SCID recipients. J. Immunol. 158:3464-3473.
13. Corry, D.B., S.L. Reiner, P.S. Linsley, and R.M. Locksley. 1994. Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. J. Immunol. 153:4142-4148.
14. + effector cells default to the Th2 pathway in interferon γ-deficient mice infected with Leishmania major. J. Exp. Med. 179:1367-1371.
15. Seder, R.A., and W.E. Paul. 1994. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol. 12:635-673.
16. Minasi, L.E., Y. Kamogawa, S. Carding, K. Bottomly, and R.A. Flavell. 1993. The selective ablation of interleukin 2-producing cells isolated from transgenic mice. J. Exp. Med. 177: 1451-1459.
17. Emmel, E.A., C.L. Verweij, D.B. Durand, K.M. Higgins, E. Lacy, and G.R. Crabtree. 1989. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. Science (Wash. DC). 246:1617-1620.
18. Verweij, C.L., C. Guidos, and G.R. Crabtree. 1990. Cell type specificity and activation requirements for NFAT-1 (nuclear factor of activated T-cells) transcriptional activity determined by a new method using transgenic mice to assay transcriptional activity of an individual nuclear factor. J. Biol. Chem. 265:15788-15795.
19. Brombacher, F., T. Schafer, U. Weissenstein, C. Tschopp, E. Andersen, K. Burki, and G. Baumann. 1994. IL-2 promoter-driven lacZ expression as a monitoring tool for IL-2 expression in primary T cells of transgenic mice. Int. Immunol. 6: 189-197.
20. + T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int. Immunol. 5:1461-1471.
21. + T cells. Immunity. 1:553-562.
22. + T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 179:589-600.
23. + T cells. J. Exp. Med. 178:237-244.
24. Reiner, S.L., and R.M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-177.
25. Huang, M., J. Wang, P. Lee, S. Sharma, J.T. Mao, H. Meissner, K. Uyemura, R. Modlin, J. Wollman, and S.M. Dubinett. 1995. Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res. 55:3847-3853.
26. Kim, J., R.L. Modlin, R.L. Moy, S.M. Dubinett, T. McHugh, B.J. Nickoloff, and K. Uyemura. 1995. IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response. J. Immunol. 155:2240-2247.
27. Mandelboim, O., G. Berke, M. Fridkin, M. Feldman, M. Eisenstein, and L. Eisenbach. 1994. CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma. Nature (Lond.). 369:67-71.
28. Kuhn, R., J. Lohler, D. Rennick, K. Rajewsky, and W. Muller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 75:263-274.
29. + T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J. Exp. Med. 184:241-251.
30. + T cells during initiation of infection. J. Exp. Med. 179:447-456.
31. Sadick, M.D., F.P. Heinzel, B.J. Holaday, R.T. Pu, R.S. Dawkins, and R.M. Locksley. 1990. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon γ-independent mechanism. J. Exp. Med. 171:115-127.
32. Kopf, M., F. Brombacher, G. Kohler, G. Kienzle, K.-H. Widmann, K. Lefrang, C. Humborg, B. Ledermann, and W. Solbach. 1996. IL-4-deficient Balb/c mice resist infection with Leishmania major. J. Exp. Med. 184:1127-1136.
33. Kopf, M., G. Le Gros, M. Bachmann, M.C. Lamers, H. Bluethmann, and G. Kohler. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature (Lond.). 362:245-248.
34. Takeda, K., T. Tanaka, W. Shi, M. Matsumoto, M. Minami, S. Kashiwamura, K. Nakanishi, N. Yoshida, T. Kishimoto, and S. Akira. 1996. Essential role of Stat6 in IL-4 signalling. Nature (Lond.). 380:627-630.
35. Shimoda K., J. van Deursen, M.Y. Sangster, S.R. Sarawar, R.T. Carson, R.A. Tripp, C. Chu, F.W. Quelle, T. Nosaka, D.A. Vignali, et al. 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature (Lond.). 380:630-633.
36. Kaplan, M.H., U. Schindler, S.T. Smiley, and M.J. Grusby. 1996. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity. 4:313-319.
37. Huang, M., S. Sharma, J.T. Mao, and S.M. Dubinett. 1996. Non-small cell lung cancer-derived soluble mediators and prostaglandin E2 enhance peripheral blood lymphocyte IL-10 transcription and protein production. J. Immunol. 157:5512-5520.
38. Suzuki, T., H. Tahara, S. Narula, K.W. Moore, P.D. Robbins, and M.T. Lotze. 1995. Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors. J. Exp. Med. 182:477-486.
39. Matsuda, M., F. Salazar, M. Petersson, G. Masucci, J. Hansson, P. Pisa, Q.J. Zhang, M.G. Masucci, and R. Kiessling. 1994. Interleukin 10 pretreatment protects target cells from tumor-and allo-specific cytotoxic T cells and downregulates HLA class I expression. J. Exp. Med. 180:2371-2376.
40. Wang, L., E. Goillot, and R.I. Tepper. 1994. IL-10 inhibits alloreactive cytotoxic T lymphocyte generation in vivo. Cell. Ilmmunol. 159:152-169.
41. Rohrer, J.W., and J.H. Coggin. 1995. CD8 T cell clones inhibit antitumor T cell function by secreting IL-10. J. Immunol. 155:5719-5727.
42. Mosmann, T.R., and K.W. Moore. 1991. The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol. Today. 12:A49-A53.
43. Murray, P.J., L. Wang, C. Onufryk, R.I. Tepper, and R.A. Young. 1997. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J. Immunol. 158:315-321.